0001171843-20-007183.txt : 20201124 0001171843-20-007183.hdr.sgml : 20201124 20201022160209 ACCESSION NUMBER: 0001171843-20-007183 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20201022 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zomedica Corp. CENTRAL INDEX KEY: 0001684144 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 100 PHOENIX DRIVE STREET 2: SUITE 180 CITY: ANN ARBOR STATE: MI ZIP: 48108 BUSINESS PHONE: (734) 369-2555 MAIL ADDRESS: STREET 1: 100 PHOENIX DRIVE STREET 2: SUITE 180 CITY: ANN ARBOR STATE: MI ZIP: 48108 FORMER COMPANY: FORMER CONFORMED NAME: Zomedica Pharmaceuticals Corp. DATE OF NAME CHANGE: 20160908 CORRESP 1 filename1.htm

Zomedica Corp.

100 Phoenix Drive, Suite 180

Ann Arbor, Michigan 48108

 

October 22, 2020

 

VIA EDGAR

 

United States Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C. 20549

 

Re:Zomedica Corp. (the “Company”)
Registration Statement on Form S-4 (File No. 333- 249401)

 

 

Ladies and Gentlemen:

 

In accordance with Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the above-referenced Registration Statement (the “Registration Statement”) be declared effective by the Securities and Exchange Commission at 9:00 a.m., Eastern Time, on October 26, 2020, or as soon as practicable thereafter.

 

Please call John D. Hogoboom of Lowenstein Sandler LLP at (973) 597-2382 to confirm the effectiveness of the Registration Statement or with any questions.

 

[Signature page follows.]

 

 

 

 

 

 

 

 

 

 

 

U.S. Securities and Exchange Commission

October 22, 2020

Page 2

 

 

Very truly yours,

 

ZOMEDICA CORP.

 

By: /s/ Ann Marie Cotter

Name: Ann Marie Cotter

Title: Chief Financial Officer

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

-2-